Hyperactive Transposase Variants Enhance Gene Integration Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for introducing DNA into cells, such as calcium phosphate, polyethylene glycol, and virus-mediated strategies, face limitations including size constraints, regulatory hurdles, and immunologic issues, with transposon systems like PiggyBac showing promise but still needing enhanced transposase activity for efficient gene transfer.
Innovation Solution
Development of hyperactive transposase variants with additional amino acid sequences, specifically a GC-rich DNA binding domain, to improve the insertion efficiency and stability of transgenes into the cellular genome.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If virus-mediated strategies are used for DNA delivery, then transfection efficiency is improved, but regulatory hurdles and immunologic problems increase
Solution Approach 1:
The patent uses transiently expressed transposase protein instead of integrating viral vectors, eliminating the need for persistent viral presence while achieving efficient DNA delivery. The transposase is expressed temporarily to catalyze transposition and then degrades, avoiding long-term immunogenicity concerns
Solution Approach 2:
The transposase acts as an intermediary enzyme that facilitates DNA integration without requiring viral particles. It mediates the transfer of therapeutic genes into host cells through a biochemical mechanism rather than viral infection, thereby avoiding immunologic responses
2Ease of manufacture
If DNA condensing reagents are used for DNA delivery, then ease of preparation is improved, but insertion efficiency into genome decreases
Solution Approach 1:
The patent replaces mechanical/chemical methods (DNA condensing and lipid transfection) with an enzymatic system. The transposase enzyme catalyzes precise DNA integration into the genome, providing high insertion efficiency while maintaining ease of preparation through simple transfection of transposase and transposon components
Solution Approach 2:
The patent modifies the transposase enzyme parameters by engineering hyperactive variants with enhanced catalytic activity and altered substrate specificity. These parameter changes enable the enzyme to efficiently integrate DNA into diverse genomic locations, overcoming the low insertion efficiency of conventional methods
3Volume of moving object
If transposon systems are used for gene transfer, then size constraints are eliminated, but transposase activity needs enhancement for efficiency
Solution Approach 1:
The patent engineers hyperactive transposase variants with modified kinetic parameters including increased catalytic rate (kcat) and optimized substrate binding. These parameter changes enable the transposase to efficiently process large DNA cargo while maintaining high transposition activity
Solution Approach 2:
The patent creates composite transposase structures by fusing the transposase enzyme with additional functional domains such as DNA binding domains or protein interaction domains. These composite structures enhance transposase activity and enable efficient transfer of large DNA constructs
Data Source
AI summary
The present invention refers to hyperactive variants of a transposase. The invention further refers to corresponding nucleic acids producing these variants, to a gene transfer system for stably introducing nucleic acid(s) into the DNA of a cell by using these hyperactive variants of a transposase and to transposons used in the inventive gene transfer system, comprising a nucleic acid sequence with flanking repeats (IRs and/or RSDs). Furthermore, applications of these transposase variants, the transposon, or the gene transfer system are also disclosed such as gene therapy, insertional mutagenesis, gene discovery (including genome mapping), mobilization of genes, library screening, or functional analysis of genomes in vivo and in vitro. Finally, pharmaceutical compositions and kits are also encompassed.